Alphatec Holdings' board of directors has approved the company's plans to acquire certain assets of Phygen, a spinal implant manufacturer based in Irvine, Calif. The purchase price for the assets is approximately $15.2 million in stock and cash. Alphatec Spine said that it expects this transaction to contribute approximately $15 million in revenue in 2013. Additional details regarding the transaction will be provided if and when the acquisition is closed.
More Articles on Orthopedic Devices:
Smith Nephew Updates Indications for Birmingham Hip Implants
Biomet Announces Lifetime Warranty on Oxford Partial Knee
EOS imaging Announces First Installation in Asia